Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Eisai CEO Sees 'Huge' Medical Need for New Diet Drug
WSJ Online
Wednesday, August 15, 2012 - 11:15am
tags:
Eisai, obesity, Haruo Naito, Belviq, Arena Pharmaceuticals
BI posts strong sales but warns of tough times ahead
Pharma Times, UK
Wednesday, August 15, 2012 - 11:13am
tags:
Boehringer Ingelheim
GSK sells Australian drugs to Aspen for $270 mln
Yahoo/Reuters
Wednesday, August 15, 2012 - 11:12am
tags:
GSK, Aspen, South Africa
Watson sues FDA on generic diabetes drug ruling
Yahoo/Reuters
Wednesday, August 15, 2012 - 11:10am
tags:
FDA, generics, Watson Pharmaceuticals, diabetes, Actos, Takeda
Democrats Caution Gilead Over Quad Pricing
Pharmalot
Wednesday, August 15, 2012 - 11:09am
tags:
drug pricing, Gilead, HIV, Quad
4 Undervalued Healthcare Stocks With Strong Inventory Trends
Seeking Alpha
Wednesday, August 15, 2012 - 11:08am
tags:
Anika, China Biologic, USANA Health Sciences
Spectrum launches FUSILEV marketing campaign
Yahoo/Fly on the Wall
Wednesday, August 15, 2012 - 11:03am
tags:
Fusilev, Spectrum Pharmaceuticals
Bristol-Myers launches patient management programs for Sprycel patients
The Fly on the Wall
Wednesday, August 15, 2012 - 11:00am
tags:
Sprycel, leukemia, Bristol-Myers Squibb
Horizon Pharma's Unsustainable Business Model
Seeking Alpha
Wednesday, August 15, 2012 - 10:59am
tags:
Horizon Pharma
Teva: Lower PE And Faster EPS Growth Than The Major Drug Makers
Seeking Alpha
Wednesday, August 15, 2012 - 10:58am
tags:
Teva Pharmaceuticals, Merck, JNJ, Pfizer, Bristol-Myers Squibb
Alnylam, AstraZeneca form strategic alliance for microRNA
Yahoo/Fly on the Wall
Wednesday, August 15, 2012 - 10:54am
tags:
microRNA, Alnylam, AstraZeneca, Regulus
Forest Labs vs Icahn Approaches Showdown Tomorrow
WSJ Online
Tuesday, August 14, 2012 - 4:03pm
tags:
Forest Labs, Carl Icahn
Will New RA Therapies Cause a Paradigm Shift?
Pharma Live
Tuesday, August 14, 2012 - 2:25pm
tags:
TNF blockers, rheumatoid arthritis, Humira, Abbott Laboratories, Pfizer, JAK inhibitors, tofacitinib, Amgen, Embrel, Remicade, JNJ
With Cytori Therapeutics, The Waiting Is The Hardest Part
Seeking Alpha
Tuesday, August 14, 2012 - 11:09am
tags:
Cytori
Merck KGaA profit helped by Rebif sales, forex
Reuters
Tuesday, August 14, 2012 - 11:07am
tags:
earnings, Merck KGaA
7 Big-Pharma Stocks With Untapped Potential
TheStreet.com
Tuesday, August 14, 2012 - 11:07am
tags:
GSK, JNJ, Bristol-Myers Squibb, Sanofi, AstraZeneca, Abbott Laboratories, Bayer
Synergy Closing Key Trial; Decision On IRWD's Linaclotide Likely To Have Impact
Yahoo/Reuters
Tuesday, August 14, 2012 - 11:05am
tags:
Synergy Pharmaceuticals, linaclotide, constipation
Carl Icahn comments on warning letter sent by FDA to Forest Labs
Yahoo/Fly on the Wall
Tuesday, August 14, 2012 - 11:04am
tags:
FDA, warnings, Forest Labs, Carl Icahn
Array BioPharma loss narrows
Reuters
Tuesday, August 14, 2012 - 11:03am
tags:
Array Biopharma, earnings
FDA clears new flu vaccine for production by 6 manufacturers
Washington Post, DC
Tuesday, August 14, 2012 - 11:02am
tags:
FDA, Flu, vaccines, flu vaccines, GSK, Sanofi, Novartis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.